Use of Phosphodiesterase Inhibitors for erectile Dysfunction is contraindicated in:
**Core Concept**
Phosphodiesterase inhibitors, such as sildenafil (Viagra), are used to treat erectile dysfunction (ED) by increasing blood flow to the penis. They work by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which breaks down cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation and increased blood flow.
**Why the Correct Answer is Right**
The contraindication to phosphodiesterase inhibitors for ED is generally related to conditions that may worsen with increased blood flow or are associated with bleeding risks. **Option C** is correct because phosphodiesterase inhibitors are contraindicated in patients with severe left ventricular outflow obstruction, such as aortic stenosis, due to the potential for increased blood pressure and cardiac workload. This is because PDE5 inhibitors can cause vasodilation and potentially worsen the obstruction.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because phosphodiesterase inhibitors are not contraindicated in patients with benign prostatic hyperplasia (BPH). In fact, some phosphodiesterase inhibitors, such as tadalafil, are approved for the treatment of BPH symptoms.
* **Option B:** This option is incorrect because phosphodiesterase inhibitors are not contraindicated in patients with diabetes. While patients with diabetes may experience erectile dysfunction, phosphodiesterase inhibitors can be effective in treating ED in these patients.
**Clinical Pearl / High-Yield Fact**
It's essential to note that phosphodiesterase inhibitors can interact with nitrates, such as nitroglycerin, and cause a potentially life-threatening drop in blood pressure. Therefore, patients taking nitrates should not use phosphodiesterase inhibitors.
**Correct Answer: C. Severe left ventricular outflow obstruction**